Aidan’s dream is to eventually box in the Summer Olympics. He is entering his first ever tournament that, if he wins, will send him on the path to qualifying in other tournaments that will get him to the US Olympic Boxing Team. In the effort to improve his physical performance, he starts taking various dietary supplements that he found from the Tungsten Supplement Company online. On day during training, Aidan collapses and is rushed to the hospital. The blood tests in the hospital show that he ingested a toxic level of an herb that is known to damage the heart. While not toxic in low doses, the herb was present in the supplement in much higher amounts than what was listed on the bottle’s label. Which of the following is TRUE about this scenario? Group of answer choices All of theses options are true. If Aidan reports the undisclosed and mislabeled substances to the FDA, the FDA will be able to immediately remove the product from the market. If the FDA is able to prove in court that the herbal ingredient in the dietary supplement caused adverse effects, it may be able to get it removed from the market. The FDA failed in its lawful responsibility to adequately test the supplement for safety and effectiveness prior to it being approved and then sold on the market.
[Answered]: Aidan’s dream is to eventually box in the Summer…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.